These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6971365)

  • 1. [Use of levamisole in liver cirrhosis].
    Patsiora MD; Glezer GA; Ershov IuA; Rachkov SM; Morozov VA
    Klin Khir (1962); 1981 Mar; (3):19-21. PubMed ID: 6971365
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dose-dependent acute effect and long-term modification by molsidomine of portal and cardiac hemodynamics in patients with liver cirrhosis].
    Hüppe D; Jäger D; Tromm A; Barmeyer J; May B
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():65-8, 76. PubMed ID: 7968910
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rheohepatographic assessment of the therapeutic effects of propranolol on portal hypertension].
    Wu XN
    Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):411-3, 446. PubMed ID: 3938325
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effects of cimetidine on splanchnic hemodynamics in cirrhotic patients with portal hypertension].
    Li S
    Zhonghua Wai Ke Za Zhi; 1993 Apr; 31(4):207-9. PubMed ID: 8275833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole therapy in chronic active liver diseases.
    Piccari GG; Sarti F; D'imperio N; Formica G; Milandri M; Soffritti M; Dal Monte PR
    Acta Gastroenterol Belg; 1978; 41(5-6):356-62. PubMed ID: 707023
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of valsartan, an angiotensin II receptor antagonist, on portal and systemic hemodynamics and on renal function in liver cirrhosis.
    Fierbinteanu-Braticevici C; Dragomir P; Tribus L; Negreanu L; Bengus A; Usvat R; Andronescu D
    J Gastrointestin Liver Dis; 2006 Dec; 15(4):337-42. PubMed ID: 17205144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of splenectomy on T cell subsets of peripheral blood lymphocytes in portal hypertension].
    Takeda A; Fujimoto Y; Yui S; Sakaguchi S; Kato N
    Nihon Geka Gakkai Zasshi; 1985 Apr; 86(4):507. PubMed ID: 3873597
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of portal hypertension with nadolol in patients with liver cirrhosis.
    Cervera J; Torres-Zamora M; Gutiérrez-Carreño R; Fierro M; Schaeffer L; Landa L
    Arch Invest Med (Mex); 1983; 14(4):331-41. PubMed ID: 6678555
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations.
    Pozsonyi T; Fehér J; Jakab L
    Allergol Immunopathol (Madr); 1981; 9(1):37-44. PubMed ID: 6973266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study of the T-lymphocytes and their subsets in the peripheral and spleen using OK and Leu series monoclonal antibodies--especially patients with idiopathic portal hypertension (IPH) and liver cirrhosis].
    Takeda A
    Nihon Geka Gakkai Zasshi; 1987 Nov; 88(11):1542-53. PubMed ID: 3501535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of molsidomine on portal and cardiac hemodynamics in liver cirrhosis].
    Hüppe D; Jäger D; Tromm A; Tunn S; Barmeyer J; May B
    Dtsch Med Wochenschr; 1991 May; 116(22):841-5. PubMed ID: 2036943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of nitrosorbide, korinfar and obzidan on the hemodynamics of patients with chronic hepatitis and liver cirrhosis based on the data acute drug trials].
    Vorob'ev LP; Maev IV
    Farmakol Toksikol; 1991; 54(5):54-7. PubMed ID: 1800153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior of blood ammonia, insulin, glucagon, renin and prolactin during propranolol therapy in cirrhosis patients with portal hypertension].
    Mazzone O; Randazzo G; Catalano D; Noè I
    Clin Ter; 1986 Jul; 118(2):109-14. PubMed ID: 3527539
    [No Abstract]   [Full Text] [Related]  

  • 15. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Levamisole treatment experience with infectious allergic bronchial asthma].
    Provotorov VM; Nikitin AV; Buravleva IV
    Klin Med (Mosk); 1981 Apr; 59(4):13-8. PubMed ID: 6972464
    [No Abstract]   [Full Text] [Related]  

  • 17. Octreotide bolus injection and azygos blood flow in patients with cirrhosis: is the effect really predictable?
    Spahr L; Giostra E; Mentha G; Hadengue A
    J Clin Gastroenterol; 2010 Oct; 44(9):e206-9. PubMed ID: 19996986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endovascular surgery and the validation of immunocorrection in patients with liver cirrhosis complicated by portal hypertension].
    Karimov ShI; Kim VF; Iunusov IR
    Vestn Khir Im I I Grek; 1991 May; 146(5):26-8. PubMed ID: 1668432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI; Arion VIa; Petunina NA
    Sov Med; 1987; (12):32-5. PubMed ID: 3502197
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physiopathological bases of the medical treatment of portal hypertension].
    Cuccurullo F; Seccia G; Porreca E; Guglielmi MD; Mezzetti A; Tomassetti V; Marzio L
    G Clin Med; 1982 Oct; 63(10):737-43. PubMed ID: 7182198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.